V.O is once again the proud winner of the 2019 Netherlands Firm of the Year Award conferred by Managing Intellectual Property. Continue reading
V.O. organises European Patent Seminar in Munich
Our firm is once again organising another European Patent Seminar in Munich between 23 and 25 September. Continue reading
New on Kluwer Patent Blog: G.D. Searle v. Sandoz B.V., Netherlands
The Court concluded that the compound darunavir was not protected by a patent within the sense of Art. 3 of the SPC directive because, following the CJEU decision in Teva v Gilead, it is necessary that the compound for which the SPC is granted can be specifically identified in the patent.